ConductScience.org, home

Paper3548841

Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.

Blume KG and 9 others. Blood, 1987. Cited by 243 papers, by iCite.

Cite this record

ConductScience Library. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Papers, record 3548841. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3548841

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies.
PubMed
Journal
Blood
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
243
iCite
Relative citation ratio, by iCite
8.5
iCite
Revised in PubMed
2021-02-16
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blume KGK G
2Forman SJS J
3O'Donnell MRM R
4Doroshow JHJ H
5Krance RAR A
6Nademanee APA P
7Snyder DSD S
8Schmidt GMG M
9Fahey JLJ L
10Metter GEG E

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
EtoposideMajor topic
LeukemiaMajor topic
Acute Disease
Adult
Child
Combined Modality Therapy
Dose-Response Relationship, Drug
Drug Evaluation
Graft vs Host Disease
Humans
Infant
Metabolic Clearance Rate
Whole-Body Irradiation

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA 30206NCI NIH HHSUnited StatesP01CA030206PubMed and NIHNIH RePORTER
CA 33572NCI NIH HHSUnited StatesP30CA033572PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.

PMIDTitleJournalYearIn PapersSource
41407462[Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma].Zhonghua Xue Ye Xue Za Zhi2025https://conductscience.org/library/papers/41407462PubMed
39147891Comparing transplant outcomes in ALL patients after myeloablative conditioning in mismatch-related or unrelated donor settings.Bone Marrow Transplant2024https://conductscience.org/library/papers/39147891PubMed
39134959
Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation.
BMC Cancer2024https://conductscience.org/library/papers/39134959PubMed
34150068The effects of comprehensive nursing interventions on the negative emotions, quality of life, and nursing satisfaction in intracerebral hemorrhage patients.Am J Transl Res2021https://conductscience.org/library/papers/34150068PubMed
32035275Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.Biol Blood Marrow Transplant2020https://conductscience.org/library/papers/32035275PubMed
31152565Technical Note: Quality assurance and relative dosimetry testing of a 60 Co total body irradiator using optical imaging.Med Phys2019https://conductscience.org/library/papers/31152565PubMed
31027384
Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present.
J Clin Med2019https://conductscience.org/library/papers/31027384PubMed
30806963Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia.Curr Hematol Malig Rep2019https://conductscience.org/library/papers/30806963PubMed
26367236
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL).
Bone Marrow Transplant2015https://conductscience.org/library/papers/26367236PubMed
26322249Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning.Exp Hematol Oncol2015https://conductscience.org/library/papers/26322249PubMed
26040247
Clinical and In Vitro Studies on Impact of High-Dose Etoposide Pharmacokinetics Prior Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia on the Risk of Post-Transplant Leukemia Relapse.
Arch Immunol Ther Exp (Warsz)2015https://conductscience.org/library/papers/26040247PubMed
25408851Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Mediterr J Hematol Infect Dis2014https://conductscience.org/library/papers/25408851PubMed
24077846Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance).Haematologica2014https://conductscience.org/library/papers/24077846PubMed
22234252Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults.Curr Opin Oncol2012https://conductscience.org/library/papers/22234252PubMed
21224011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.
Biol Blood Marrow Transplant2011https://conductscience.org/library/papers/21224011PubMed
20531287Autologous hematopoietic cell transplantation for high-risk ALL.Bone Marrow Transplant2011https://conductscience.org/library/papers/20531287PubMed
20062098Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.Bone Marrow Transplant2010https://conductscience.org/library/papers/20062098PubMed
19786984Cyclophosphamide and cancer: golden anniversary.Nat Rev Clin Oncol2009https://conductscience.org/library/papers/19786984PubMed
19244158
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993.
Blood2009https://conductscience.org/library/papers/19244158PubMed
18519812
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
Blood2008https://conductscience.org/library/papers/18519812PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3548841

GET https://conductscience.org/api/papers/v1/3548841/cited_by?page=2